135 related articles for article (PubMed ID: 24829796)
1. Beneficial Effect of Glucose Control on Atherosclerosis Progression in Diabetic ApoE(-/-) Mice: Shown by Rage Directed Imaging.
Tekabe Y; Kollaros M; Li Q; Zhang G; Li C; Schmidt AM; Johnson LL
Int J Mol Imaging; 2014; 2014():695391. PubMed ID: 24829796
[TBL] [Abstract][Full Text] [Related]
2. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
[TBL] [Abstract][Full Text] [Related]
3. A novel monoclonal antibody for RAGE-directed imaging identifies accelerated atherosclerosis in diabetes.
Tekabe Y; Luma J; Einstein AJ; Sedlar M; Li Q; Schmidt AM; Johnson LL
J Nucl Med; 2010 Jan; 51(1):92-7. PubMed ID: 20008983
[TBL] [Abstract][Full Text] [Related]
4. Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigs.
Johnson LL; Tekabe Y; Kollaros M; Eng G; Bhatia K; Li C; Krueger CG; Shanmuganayagam D; Schmidt AM
EJNMMI Res; 2014; 4():26. PubMed ID: 25006545
[TBL] [Abstract][Full Text] [Related]
5. Imaging VEGF receptor expression to identify accelerated atherosclerosis.
Tekabe Y; Kollaros M; Zerihoun A; Zhang G; Backer MV; Backer JM; Johnson LL
EJNMMI Res; 2014 Dec; 4(1):41. PubMed ID: 26055940
[TBL] [Abstract][Full Text] [Related]
6. Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury.
Tekabe Y; Luma J; Li Q; Schmidt AM; Ramasamy R; Johnson LL
JACC Cardiovasc Imaging; 2012 Jan; 5(1):59-67. PubMed ID: 22239894
[TBL] [Abstract][Full Text] [Related]
7. Single-photon emission computed tomography/computed tomography imaging of RAGE in smoking-induced lung injury.
Goldklang MP; Tekabe Y; Zelonina T; Trischler J; Xiao R; Stearns K; Rodriguez K; Shields A; Romanov A; D'Armiento JM; Johnson LL
Respir Res; 2019 Jun; 20(1):116. PubMed ID: 31182072
[TBL] [Abstract][Full Text] [Related]
8. Imaging receptor for advanced glycation end product expression in mouse model of hind limb ischemia.
Tekabe Y; Kollaros M; Li C; Zhang G; Schmidt AM; Johnson L
EJNMMI Res; 2013 May; 3(1):37. PubMed ID: 23663412
[TBL] [Abstract][Full Text] [Related]
9. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
[TBL] [Abstract][Full Text] [Related]
10. Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE
Tekabe Y; Johnson LL; Rodriquez K; Li Q; Backer M; Backer JM
Mol Imaging Biol; 2018 Feb; 20(1):85-93. PubMed ID: 28421362
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling.
Gao H; Li H; Li W; Shen X; Di B
Med Sci Monit; 2017 Dec; 23():6121-6131. PubMed ID: 29278639
[TBL] [Abstract][Full Text] [Related]
12. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.
Bu DX; Rai V; Shen X; Rosario R; Lu Y; D'Agati V; Yan SF; Friedman RA; Nuglozeh E; Schmidt AM
Circ Res; 2010 Apr; 106(6):1040-51. PubMed ID: 20133903
[TBL] [Abstract][Full Text] [Related]
13. Novel Receptor for Advanced Glycation End Products-Blocking Antibody to Treat Diabetic Peripheral Artery Disease.
Johnson LL; Johnson J; Ober R; Holland A; Zhang G; Backer M; Backer J; Ali Z; Tekabe Y
J Am Heart Assoc; 2021 Jan; 10(1):e016696. PubMed ID: 33327730
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5.
Isobe S; Tsimikas S; Zhou J; Fujimoto S; Sarai M; Branks MJ; Fujimoto A; Hofstra L; Reutelingsperger CP; Murohara T; Virmani R; Kolodgie FD; Narula N; Petrov A; Narula J
J Nucl Med; 2006 Sep; 47(9):1497-505. PubMed ID: 16954559
[TBL] [Abstract][Full Text] [Related]
15. Treatment effect with anti-RAGE F(ab')2 antibody improves hind limb angiogenesis and blood flow in Type 1 diabetic mice with left femoral artery ligation.
Tekabe Y; Anthony T; Li Q; Ray R; Rai V; Zhang G; Schmidt AM; Johnson LL
Vasc Med; 2015 Jun; 20(3):212-8. PubMed ID: 25808570
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
Soro-Paavonen A; Watson AM; Li J; Paavonen K; Koitka A; Calkin AC; Barit D; Coughlan MT; Drew BG; Lancaster GI; Thomas M; Forbes JM; Nawroth PP; Bierhaus A; Cooper ME; Jandeleit-Dahm KA
Diabetes; 2008 Sep; 57(9):2461-9. PubMed ID: 18511846
[TBL] [Abstract][Full Text] [Related]
17. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.
Bucciarelli LG; Wendt T; Qu W; Lu Y; Lalla E; Rong LL; Goova MT; Moser B; Kislinger T; Lee DC; Kashyap Y; Stern DM; Schmidt AM
Circulation; 2002 Nov; 106(22):2827-35. PubMed ID: 12451010
[TBL] [Abstract][Full Text] [Related]
18. Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis.
Koulis C; Kanellakis P; Pickering RJ; Tsorotes D; Murphy AJ; Gray SP; Thomas MC; Jandeleit-Dahm KA; Cooper ME; Allen TJ
Clin Sci (Lond); 2014 Oct; 127(7):485-97. PubMed ID: 24724734
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
